VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q46831235 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010713.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q46831235‏
024 ‎‡a 0000-0003-4465-1043‏ ‎‡2 orcid‏
024 ‎‡a 14918864300‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q46831235‏
100 0 ‎‡a Maurizio Ponz de Leon‏ ‎‡9 ast‏ ‎‡9 es‏ ‎‡9 sl‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Maurizio Ponz de Leon‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Maurizio Ponz de Leon‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A case of pneumatosis cystoides intestinalis mimicking familial adenomatous polyposis.‏
670 ‎‡a Author's A founder MLH1 mutation in families from the districts of Modena and Reggio-Emilia in northern Italy with hereditary non-polyposis colorectal cancer associated with protein elongation and instability.‏
670 ‎‡a Author's Aberrant crypt foci in patients with colorectal cancer.‏
670 ‎‡a Author's Alteration of Drug Metabolism During Cholestasis in Man‏
670 ‎‡a Author's An unusual case of familial adenomatous polyposis with very early symptom occurrence.‏
670 ‎‡a Author's Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome‏
670 ‎‡a Author's Argyrophilic nucleolar organizer regions and bromodeoxyuridine and3[H]-thymidine labelling indices in colorectal cancer‏
670 ‎‡a Author's Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations‏
670 ‎‡a Author's Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies‏
670 ‎‡a Author's Autoradiographic and flow-cytometric assessment of cell proliferation in primary colorectal cancer: relationship to DNA ploidy and clinico-pathological features‏
670 ‎‡a Author's Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study.‏
670 ‎‡a Author's Cell kinetics evaluation of colorectal tumors afterin vivo administration of bromodeoxyuridine‏
670 ‎‡a Author's Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer‏
670 ‎‡a Author's Clinical and biologic heterogeneity of hereditary nonpolyposis colorectal cancer‏
670 ‎‡a Author's Clinical and molecular features of attenuated adenomatous polyposis in northern Italy.‏
670 ‎‡a Author's Clinical and pathologic prognostic indicators in colorectal cancer. A population-based study‏
670 ‎‡a Author's Clinical features, frequency and prognosis of Dukes' A colorectal carcinoma: A population-based investigation‏
670 ‎‡a Author's Clinical outcome of low- and high-risk malignant colorectal polyps: results of a population-based study and meta-analysis of the available literature.‏
670 ‎‡a Author's Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme‏
670 ‎‡a Author's Correlation between bromodeoxyuridine labelling and ornithine decarboxylase levels in normal rectal mucosa of patients with colorectal adenoma‏
670 ‎‡a Author's Decrease in plasma tryptophan after a tryptophan-free amino acid solution. A comparison between cirrhotic and control subjects‏
670 ‎‡a Author's Different molecular mechanisms underlie genomic deletions in the MLH1 Gene‏
670 ‎‡a Author's Disease presentation, treatment and survival for Italian colorectal cancer patients: a EUROCARE high resolution study‏
670 ‎‡a Author's Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors‏
670 ‎‡a Author's Duodenal carcinoma in a 37-year-old man with Cowden/Bannayan syndrome.‏
670 ‎‡a Author's Effects of acute changes of bile acid pool composition on biliary lipid secretion.‏
670 ‎‡a Author's Epidemiology of colorectal cancer: the 21-year experience of a specialised registry.‏
670 ‎‡a Author's Familial aggregation of tumors and detection of hereditary non-polyposis colorectal cancer in 3-year experience of 2 population-based colorectal-cancer registries‏
670 ‎‡a Author's Familial occurrence of gastric cancer in the 2-year experience of a population-based registry‏
670 ‎‡a Author's First observation of microadenomas in the ileal mucosa of patients with familial adenomatous polyposis and colectomies.‏
670 ‎‡a Author's Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma‏
670 ‎‡a Author's Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC‏
670 ‎‡a Author's Frequency of upper gastrointestinal lesions in patients with liver cirrhosis‏
670 ‎‡a Author's Genetic epidemiology of hereditary non-polyposis colorectal cancer syndromes in Modena, Italy: results of a complex segregation analysis‏
670 ‎‡a Author's Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer.‏
670 ‎‡a Author's Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts‏
670 ‎‡a Author's Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer‏
670 ‎‡a Author's Histology of aberrant crypt foci in the human colon.‏
670 ‎‡a Author's Identification and classification of hereditary nonpolyposis colorectal cancer (Lynch syndrome): adapting old concepts to recent advancements. Report from the Italian Association for the study of Hereditary Colorectal Tumors Consensus Group‏
670 ‎‡a Author's Identification of hereditary nonpolyposis colorectal cancer in the general population. The 6-year experience of a population-based registry‏
670 ‎‡a Author's Identification of Lynch syndrome among patients with colorectal cancer‏
670 ‎‡a Author's Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas‏
670 ‎‡a Author's Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis.‏
670 ‎‡a Author's Impact of surgery on the development of duodenal cancer in patients with familial adenomatous polyposis.‏
670 ‎‡a Author's Incidence trend of malignant polyps through the data of a specialized colorectal cancer registry: clinical features and effect of screening‏
670 ‎‡a Author's Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients‏
670 ‎‡a Author's Infliximab-related hepatitis: discussion of a case and review of the literature.‏
670 ‎‡a Author's Inheritance and susceptibility to tumours of the large bowel: a new classification of colorectal malignancies.‏
670 ‎‡a Author's Integrated analysis of unclassified variants in mismatch repair genes‏
670 ‎‡a Author's K-ras andp53 mutations in hereditary non-polyposis colorectal cancers‏
670 ‎‡a Author's Long-term survey of patients with curable colorectal cancer with specific reference to the quality of life‏
670 ‎‡a Author's Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: a population-based study.‏
670 ‎‡a Author's Lymph node micrometastasis and survival of patients with Stage I (Dukes' A) colorectal carcinoma‏
670 ‎‡a Author's Management of rectal cancers in relation to treatment guidelines: a population-based study comparing Italian and French patients‏
670 ‎‡a Author's Matrix metalloproteinases 15 and 19 are stromal regulators of colorectal cancer development from the early stages‏
670 ‎‡a Author's Methylation pattern of different regions of theMLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer‏
670 ‎‡a Author's Microsatellite instability and colorectal cancer prognosis.‏
670 ‎‡a Author's Mismatch repair genes and mononucleotide tracts as mutation targets in colorectal tumors with different degrees of microsatellite instability‏
670 ‎‡a Author's MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer‏
670 ‎‡a Author's Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes.‏
670 ‎‡a Author's Muir-Torre syndrome.‏
670 ‎‡a Author's MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events‏
670 ‎‡a Author's Neutrophil gelatinase-associated lipocalin: a new prognostic marker in stage I colorectal carcinoma?‏
670 ‎‡a Author's Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma‏
670 ‎‡a Author's Pattern of cell kinetics in colorectal mucosa of patients with different types of adenomatous polyps of the large bowel‏
670 ‎‡a Author's Phenotype-genotype correlations in an extended family with adenomatosis coli and an unusual APC gene mutation‏
670 ‎‡a Author's PLZF expression during colorectal cancer development and in normal colorectal mucosa according to body size, as marker of colorectal cancer risk‏
670 ‎‡a Author's Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas.‏
670 ‎‡a Author's Recommendations to improve identification of hereditary and familial colorectal cancer in Europe.‏
670 ‎‡a Author's Regional inequalities in cancer care persist in Italy and can influence survival‏
670 ‎‡a Author's Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas‏
670 ‎‡a Author's Relative role of APC and MUTYH mutations in the pathogenesis of familial adenomatous polyposis.‏
670 ‎‡a Author's Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts‏
670 ‎‡a Author's Risk of cancer revealed by follow-up of families with hereditary non-polyposis colorectal cancer: A population-based study‏
670 ‎‡a Author's Risk of cancer revealed by follow-up of families with hereditary non-polyposis colorectal cancer: Reply to Dr. Eluf-Neto‏
670 ‎‡a Author's Role of clinical criteria in the diagnosis of hereditary non-polyposis colorectal cancer‏
670 ‎‡a Author's Role of clinical criteria in the diagnosis of hereditary non-polyposis colorectal cancer (HNPCC): results of a multivariate analysis.‏
670 ‎‡a Author's Stage I colorectal carcinoma: VEGF immunohistochemical expression, microvessel density, and their correlation with clinical outcome‏
670 ‎‡a Author's Survival analysis in families affected by hereditary non-polyposis colorectal cancer‏
670 ‎‡a Author's Survival of colorectal cancer patients in Europe during the period 1978–1989‏
670 ‎‡a Author's Suspected hereditary nonpolyposis colorectal cancer‏
670 ‎‡a Author's Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study.‏
670 ‎‡a Author's Th inducing POZ-Kruppel Factor‏
670 ‎‡a Author's Th inducing POZ-Kruppel Factor (ThPOK) is a key regulator of the immune response since the early steps of colorectal carcinogenesis‏
670 ‎‡a Author's The effect of family size on estimates of the frequency of hereditary non-polyposis colorectal cancer.‏
670 ‎‡a Author's The obesity epidemic‏
670 ‎‡a Author's The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer‏
670 ‎‡a Author's The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study‏
670 ‎‡a Author's Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry‏
670 ‎‡a Author's Tumour spectrum in hereditary non-polyposis colorectal cancer‏
670 ‎‡a Author's Tumour spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with "suspected HNPCC". A population-based study in northern Italy. Colorectal Cancer Study Group.‏
670 ‎‡a Author's Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study‏
670 ‎‡a Author's What should we advise about alcohol consumption‏
909 ‎‡a (orcid) 0000000344651043‏ ‎‡9 1‏
909 ‎‡a (scopus) 14918864300‏ ‎‡9 1‏
919 ‎‡a tumourspectruminhereditarynonpolyposiscolorectalcancerhnpccandinfamilieswithsuspectedhnpccapopulationbasedstudyinnorthernitalycolorectalcancerstudygroup‏ ‎‡A Tumour spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with "suspected HNPCC". A population-based study in northern Italy. Colorectal Cancer Study Group.‏ ‎‡9 1‏
919 ‎‡a tumourspectruminhereditarynonpolyposiscolorectalcancer‏ ‎‡A Tumour spectrum in hereditary non-polyposis colorectal cancer‏ ‎‡9 1‏
919 ‎‡a trendofincidencesubsitedistributionandstagingofcolorectalneoplasmsinthe15yearexperienceofaspecialisedcancerregistry‏ ‎‡A Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry‏ ‎‡9 1‏
919 ‎‡a reliabilityofimmunohistochemistryasaprescreeningmethodforthediagnosisofhereditarynonpolyposiscolorectalcancerhnpccresultsofaninternationalcollaborativestudy‏ ‎‡A The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study‏ ‎‡9 1‏
919 ‎‡a reliabilityofimmunohistochemistryasaprescreeningmethodforthediagnosisofhereditarynonpolyposiscolorectalcancer‏ ‎‡A The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer‏ ‎‡9 1‏
919 ‎‡a obesityepidemic‏ ‎‡A The obesity epidemic‏ ‎‡9 1‏
919 ‎‡a effectoffamilysizeonestimatesofthefrequencyofhereditarynonpolyposiscolorectalcancer‏ ‎‡A The effect of family size on estimates of the frequency of hereditary non-polyposis colorectal cancer.‏ ‎‡9 1‏
919 ‎‡a thinducingpozkruppelfactorthpokisakeyregulatoroftheimmuneresponsesincetheearlystepsofcolorectalcarcinogenesis‏ ‎‡A Th inducing POZ-Kruppel Factor (ThPOK) is a key regulator of the immune response since the early steps of colorectal carcinogenesis‏ ‎‡9 1‏
919 ‎‡a thinducingpozkruppelfactor‏ ‎‡A Th inducing POZ-Kruppel Factor‏ ‎‡9 1‏
919 ‎‡a suspectedhnpccandamsterdamcriteria2evaluationofmutationdetectionrateaninternationalcollaborativestudy‏ ‎‡A Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study.‏ ‎‡9 1‏
919 ‎‡a caseofpneumatosiscystoidesintestinalismimickingfamilialadenomatouspolyposis‏ ‎‡A A case of pneumatosis cystoides intestinalis mimicking familial adenomatous polyposis.‏ ‎‡9 1‏
919 ‎‡a foundermlh1mutationinfamiliesfromthedistrictsofmodenaandreggioemiliainnorthernitalywithhereditarynonpolyposiscolorectalcancerassociatedwithproteinelongationandinstability‏ ‎‡A A founder MLH1 mutation in families from the districts of Modena and Reggio-Emilia in northern Italy with hereditary non-polyposis colorectal cancer associated with protein elongation and instability.‏ ‎‡9 1‏
919 ‎‡a aberrantcryptfociinpatientswithcolorectalcancer‏ ‎‡A Aberrant crypt foci in patients with colorectal cancer.‏ ‎‡9 1‏
919 ‎‡a alterationofdrugmetabolismduringcholestasisinman‏ ‎‡A Alteration of Drug Metabolism During Cholestasis in Man‏ ‎‡9 1‏
919 ‎‡a unusualcaseoffamilialadenomatouspolyposiswithveryearlysymptomoccurrence‏ ‎‡A An unusual case of familial adenomatous polyposis with very early symptom occurrence.‏ ‎‡9 1‏
919 ‎‡a analysisoftelomeredynamicsinperipheralbloodcellsfrompatientswithlynchsyndrome‏ ‎‡A Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome‏ ‎‡9 1‏
919 ‎‡a argyrophilicnucleolarorganizerregionsandbromodeoxyuridineand3thymidinelabellingindicesincolorectalcancer‏ ‎‡A Argyrophilic nucleolar organizer regions and bromodeoxyuridine and3[H]-thymidine labelling indices in colorectal cancer‏ ‎‡9 1‏
919 ‎‡a attenuatedfamilialadenomatouspolyposisandmuirtorresyndromelinkedtocompoundbiallelicconstitutionalmyhgenemutations‏ ‎‡A Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations‏ ‎‡9 1‏
919 ‎‡a attitudeoftheitaliangeneralpopulationtowardspreventionandscreeningofthemostcommontumorswithspecialemphasisoncolorectalmalignancies‏ ‎‡A Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies‏ ‎‡9 1‏
919 ‎‡a autoradiographicandflowcytometricassessmentofcellproliferationinprimarycolorectalcancerrelationshiptodnaploidyandclinicopathologicalfeatures‏ ‎‡A Autoradiographic and flow-cytometric assessment of cell proliferation in primary colorectal cancer: relationship to DNA ploidy and clinico-pathological features‏ ‎‡9 1‏
919 ‎‡a cancerriskassociatedwithstk11lkb1germlinemutationsinpeutzjegherssyndromepatientsresultsofanitalianmulticenterstudy‏ ‎‡A Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study.‏ ‎‡9 1‏
919 ‎‡a cellkineticsevaluationofcolorectaltumorsafterinvivoadministrationofbromodeoxyuridine‏ ‎‡A Cell kinetics evaluation of colorectal tumors afterin vivo administration of bromodeoxyuridine‏ ‎‡9 1‏
919 ‎‡a characterizationofmsh2andmlh1mutationsinitalianfamilieswithhereditarynonpolyposiscolorectalcancer‏ ‎‡A Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer‏ ‎‡9 1‏
919 ‎‡a clinicalandbiologicheterogeneityofhereditarynonpolyposiscolorectalcancer‏ ‎‡A Clinical and biologic heterogeneity of hereditary nonpolyposis colorectal cancer‏ ‎‡9 1‏
919 ‎‡a clinicalandmolecularfeaturesofattenuatedadenomatouspolyposisinnorthernitaly‏ ‎‡A Clinical and molecular features of attenuated adenomatous polyposis in northern Italy.‏ ‎‡9 1‏
919 ‎‡a clinicalandpathologicprognosticindicatorsincolorectalcancerapopulationbasedstudy‏ ‎‡A Clinical and pathologic prognostic indicators in colorectal cancer. A population-based study‏ ‎‡9 1‏
919 ‎‡a clinicalfeaturesfrequencyandprognosisofdukesacolorectalcarcinomaapopulationbasedinvestigation‏ ‎‡A Clinical features, frequency and prognosis of Dukes' A colorectal carcinoma: A population-based investigation‏ ‎‡9 1‏
919 ‎‡a clinicaloutcomeoflowandhighriskmalignantcolorectalpolypsresultsofapopulationbasedstudyandmetaanalysisoftheavailableliterature‏ ‎‡A Clinical outcome of low- and high-risk malignant colorectal polyps: results of a population-based study and meta-analysis of the available literature.‏ ‎‡9 1‏
919 ‎‡a colonoscopicsurveillanceof1degreerelativesofcolorectalcancerpatientsinafaecaloccultbloodscreeningprogramme‏ ‎‡A Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme‏ ‎‡9 1‏
919 ‎‡a correlationbetweenbromodeoxyuridinelabellingandornithinedecarboxylaselevelsinnormalrectalmucosaofpatientswithcolorectaladenoma‏ ‎‡A Correlation between bromodeoxyuridine labelling and ornithine decarboxylase levels in normal rectal mucosa of patients with colorectal adenoma‏ ‎‡9 1‏
919 ‎‡a decreaseinplasmatryptophanafteratryptophanfreeaminoacidsolutionacomparisonbetweencirrhoticandcontrolsubjects‏ ‎‡A Decrease in plasma tryptophan after a tryptophan-free amino acid solution. A comparison between cirrhotic and control subjects‏ ‎‡9 1‏
919 ‎‡a differentmolecularmechanismsunderliegenomicdeletionsinthemlh1gene‏ ‎‡A Different molecular mechanisms underlie genomic deletions in the MLH1 Gene‏ ‎‡9 1‏
919 ‎‡a diseasepresentationtreatmentandsurvivalforitaliancolorectalcancerpatientsaeurocarehighresolutionstudy‏ ‎‡A Disease presentation, treatment and survival for Italian colorectal cancer patients: a EUROCARE high resolution study‏ ‎‡9 1‏
919 ‎‡a doubleheterozygosityforbrca1andhmlh1genemutationsina46yearoldwomanwith5primarytumors‏ ‎‡A Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors‏ ‎‡9 1‏
919 ‎‡a duodenalcarcinomaina37yearoldmanwithcowdenbannayansyndrome‏ ‎‡A Duodenal carcinoma in a 37-year-old man with Cowden/Bannayan syndrome.‏ ‎‡9 1‏
919 ‎‡a effectsofacutechangesofbileacidpoolcompositiononbiliarylipidsecretion‏ ‎‡A Effects of acute changes of bile acid pool composition on biliary lipid secretion.‏ ‎‡9 1‏
919 ‎‡a epidemiologyofcolorectalcancerthe21yearexperienceofaspecialisedregistry‏ ‎‡A Epidemiology of colorectal cancer: the 21-year experience of a specialised registry.‏ ‎‡9 1‏
919 ‎‡a familialaggregationoftumorsanddetectionofhereditarynonpolyposiscolorectalcancerin3yearexperienceof2populationbasedcolorectalcancerregistries‏ ‎‡A Familial aggregation of tumors and detection of hereditary non-polyposis colorectal cancer in 3-year experience of 2 population-based colorectal-cancer registries‏ ‎‡9 1‏
919 ‎‡a familialoccurrenceofgastriccancerinthe2yearexperienceofapopulationbasedregistry‏ ‎‡A Familial occurrence of gastric cancer in the 2-year experience of a population-based registry‏ ‎‡9 1‏
919 ‎‡a 1observationofmicroadenomasintheilealmucosaofpatientswithfamilialadenomatouspolyposisandcolectomies‏ ‎‡A First observation of microadenomas in the ileal mucosa of patients with familial adenomatous polyposis and colectomies.‏ ‎‡9 1‏
919 ‎‡a frequencyandclinicalfeaturesofmultipletumorsofthelargebowelinthegeneralpopulationandinpatientswithhereditarycolorectalcarcinoma‏ ‎‡A Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma‏ ‎‡9 1‏
919 ‎‡a frequencyofconstitutionalmsh6mutationsinaconsecutiveseriesoffamilieswithclinicalsuspicionofhnpcc‏ ‎‡A Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC‏ ‎‡9 1‏
919 ‎‡a frequencyofuppergastrointestinallesionsinpatientswithlivercirrhosis‏ ‎‡A Frequency of upper gastrointestinal lesions in patients with liver cirrhosis‏ ‎‡9 1‏
919 ‎‡a geneticepidemiologyofhereditarynonpolyposiscolorectalcancersyndromesinmodenaitalyresultsofacomplexsegregationanalysis‏ ‎‡A Genetic epidemiology of hereditary non-polyposis colorectal cancer syndromes in Modena, Italy: results of a complex segregation analysis‏ ‎‡9 1‏
919 ‎‡a genetictestingamonghighriskindividualsinfamilieswithhereditarynonpolyposiscolorectalcancer‏ ‎‡A Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer.‏ ‎‡9 1‏
919 ‎‡a genomicinstabilityandtargetgenemutationsincoloncancerswithdifferentdegreesofallelicshifts‏ ‎‡A Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts‏ ‎‡9 1‏
919 ‎‡a genotypephenotypecorrelationsinindividualswithafoundermutationinthemlh1geneandhereditarynonpolyposiscolorectalcancer‏ ‎‡A Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer‏ ‎‡9 1‏
919 ‎‡a histologyofaberrantcryptfociinthehumancolon‏ ‎‡A Histology of aberrant crypt foci in the human colon.‏ ‎‡9 1‏
919 ‎‡a identificationandclassificationofhereditarynonpolyposiscolorectalcancerlynchsyndromeadaptingoldconceptstorecentadvancementsreportfromtheitalianassociationforthestudyofhereditarycolorectaltumorsconsensusgroup‏ ‎‡A Identification and classification of hereditary nonpolyposis colorectal cancer (Lynch syndrome): adapting old concepts to recent advancements. Report from the Italian Association for the study of Hereditary Colorectal Tumors Consensus Group‏ ‎‡9 1‏
919 ‎‡a identificationofhereditarynonpolyposiscolorectalcancerinthegeneralpopulationthe6yearexperienceofapopulationbasedregistry‏ ‎‡A Identification of hereditary nonpolyposis colorectal cancer in the general population. The 6-year experience of a population-based registry‏ ‎‡9 1‏
919 ‎‡a identificationoflynchsyndromeamongpatientswithcolorectalcancer‏ ‎‡A Identification of Lynch syndrome among patients with colorectal cancer‏ ‎‡9 1‏
919 ‎‡a identificationofmuirtorresyndromeamongpatientswithsebaceoustumorsandkeratoacanthomas‏ ‎‡A Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas‏ ‎‡9 1‏
919 ‎‡a immunohistochemicalexpressionofmyhproteincanbeusedtoidentifypatientswithmyhassociatedpolyposis‏ ‎‡A Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis.‏ ‎‡9 1‏
919 ‎‡a impactofsurgeryonthedevelopmentofduodenalcancerinpatientswithfamilialadenomatouspolyposis‏ ‎‡A Impact of surgery on the development of duodenal cancer in patients with familial adenomatous polyposis.‏ ‎‡9 1‏
919 ‎‡a incidencetrendofmalignantpolypsthroughthedataofaspecializedcolorectalcancerregistryclinicalfeaturesandeffectofscreening‏ ‎‡A Incidence trend of malignant polyps through the data of a specialized colorectal cancer registry: clinical features and effect of screening‏ ‎‡9 1‏
919 ‎‡a increasedexpressionofcd133isastrongpredictorofpooroutcomeinstage1colorectalcancerpatients‏ ‎‡A Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients‏ ‎‡9 1‏
919 ‎‡a infliximabrelatedhepatitisdiscussionofacaseandreviewoftheliterature‏ ‎‡A Infliximab-related hepatitis: discussion of a case and review of the literature.‏ ‎‡9 1‏
919 ‎‡a inheritanceandsusceptibilitytotumoursofthelargebowelanewclassificationofcolorectalmalignancies‏ ‎‡A Inheritance and susceptibility to tumours of the large bowel: a new classification of colorectal malignancies.‏ ‎‡9 1‏
919 ‎‡a integratedanalysisofunclassifiedvariantsinmismatchrepairgenes‏ ‎‡A Integrated analysis of unclassified variants in mismatch repair genes‏ ‎‡9 1‏
919 ‎‡a krasandp53mutationsinhereditarynonpolyposiscolorectalcancers‏ ‎‡A K-ras andp53 mutations in hereditary non-polyposis colorectal cancers‏ ‎‡9 1‏
919 ‎‡a longtermsurveyofpatientswithcurablecolorectalcancerwithspecificreferencetothequalityoflife‏ ‎‡A Long-term survey of patients with curable colorectal cancer with specific reference to the quality of life‏ ‎‡9 1‏
919 ‎‡a lymphnodeevaluationinstageiiacolorectalcanceranditsimpactonpatientprognosisapopulationbasedstudy‏ ‎‡A Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: a population-based study.‏ ‎‡9 1‏
919 ‎‡a lymphnodemicrometastasisandsurvivalofpatientswithstage1dukesacolorectalcarcinoma‏ ‎‡A Lymph node micrometastasis and survival of patients with Stage I (Dukes' A) colorectal carcinoma‏ ‎‡9 1‏
919 ‎‡a managementofrectalcancersinrelationtotreatmentguidelinesapopulationbasedstudycomparingitalianandfrenchpatients‏ ‎‡A Management of rectal cancers in relation to treatment guidelines: a population-based study comparing Italian and French patients‏ ‎‡9 1‏
919 ‎‡a matrixmetalloproteinases15and19arestromalregulatorsofcolorectalcancerdevelopmentfromtheearlystages‏ ‎‡A Matrix metalloproteinases 15 and 19 are stromal regulators of colorectal cancer development from the early stages‏ ‎‡9 1‏
919 ‎‡a methylationpatternofdifferentregionsofthemlh1promoterandsilencingofgeneexpressioninhereditaryandsporadiccolorectalcancer‏ ‎‡A Methylation pattern of different regions of theMLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer‏ ‎‡9 1‏
919 ‎‡a microsatelliteinstabilityandcolorectalcancerprognosis‏ ‎‡A Microsatellite instability and colorectal cancer prognosis.‏ ‎‡9 1‏
919 ‎‡a mismatchrepairgenesandmononucleotidetractsasmutationtargetsincolorectaltumorswithdifferentdegreesofmicrosatelliteinstability‏ ‎‡A Mismatch repair genes and mononucleotide tracts as mutation targets in colorectal tumors with different degrees of microsatellite instability‏ ‎‡9 1‏
919 ‎‡a mlh1andmsh2constitutionalmutationsincolorectalcancerfamiliesnotmeetingthestandardcriteriaforhereditarynonpolyposiscolorectalcancer‏ ‎‡A MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer‏ ‎‡9 1‏
919 ‎‡a moleculargeneticalterationsandclinicalfeaturesinearlyonsetcolorectalcarcinomasandtheirrolefortherecognitionofhereditarycancersyndromes‏ ‎‡A Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes.‏ ‎‡9 1‏
919 ‎‡a muirtorresyndrome‏ ‎‡A Muir-Torre syndrome.‏ ‎‡9 1‏
919 ‎‡a mutyhassociatedpolyposismapevidencefortheoriginofthecommoneuropeanmutationsptyr179cysandpgly396aspbyfounderevents‏ ‎‡A MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events‏ ‎‡9 1‏
919 ‎‡a neutrophilgelatinaseassociatedlipocalinanewprognosticmarkerinstage1colorectalcarcinoma‏ ‎‡A Neutrophil gelatinase-associated lipocalin: a new prognostic marker in stage I colorectal carcinoma?‏ ‎‡9 1‏
919 ‎‡a neutrophilgelatinaseassociatedlipocalinngalandmatrixmetalloproteinase9mmp9prognosticvalueinstage1colorectalcarcinoma‏ ‎‡A Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma‏ ‎‡9 1‏
919 ‎‡a patternofcellkineticsincolorectalmucosaofpatientswithdifferenttypesofadenomatouspolypsofthelargebowel‏ ‎‡A Pattern of cell kinetics in colorectal mucosa of patients with different types of adenomatous polyps of the large bowel‏ ‎‡9 1‏
919 ‎‡a phenotypegenotypecorrelationsinanextendedfamilywithadenomatosiscoliandanunusualapcgenemutation‏ ‎‡A Phenotype-genotype correlations in an extended family with adenomatosis coli and an unusual APC gene mutation‏ ‎‡9 1‏
919 ‎‡a plzfexpressionduringcolorectalcancerdevelopmentandinnormalcolorectalmucosaaccordingtobodysizeasmarkerofcolorectalcancerrisk‏ ‎‡A PLZF expression during colorectal cancer development and in normal colorectal mucosa according to body size, as marker of colorectal cancer risk‏ ‎‡9 1‏
919 ‎‡a prevalenceofthey165cg382dand1395delggagermlinemutationsofthemyhgeneinitalianpatientswithadenomatouspolyposiscoliandcolorectaladenomas‏ ‎‡A Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas.‏ ‎‡9 1‏
919 ‎‡a recommendationstoimproveidentificationofhereditaryandfamilialcolorectalcancerineurope‏ ‎‡A Recommendations to improve identification of hereditary and familial colorectal cancer in Europe.‏ ‎‡9 1‏
919 ‎‡a regionalinequalitiesincancercarepersistinitalyandcaninfluencesurvival‏ ‎‡A Regional inequalities in cancer care persist in Italy and can influence survival‏ ‎‡9 1‏
919 ‎‡a relationshipbetweenmuc5acandalteredexpressionofmlh1proteininmucinousandnonmucinouscolorectalcarcinomas‏ ‎‡A Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas‏ ‎‡9 1‏
919 ‎‡a relativeroleofapcandmutyhmutationsinthepathogenesisoffamilialadenomatouspolyposis‏ ‎‡A Relative role of APC and MUTYH mutations in the pathogenesis of familial adenomatous polyposis.‏ ‎‡9 1‏
919 ‎‡a revisedguidelinesfortheclinicalmanagementoflynchsyndromehnpccrecommendationsbyagroupofeuropeanexperts‏ ‎‡A Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts‏ ‎‡9 1‏
919 ‎‡a riskofcancerrevealedbyfollowupoffamilieswithhereditarynonpolyposiscolorectalcancerapopulationbasedstudy‏ ‎‡A Risk of cancer revealed by follow-up of families with hereditary non-polyposis colorectal cancer: A population-based study‏ ‎‡9 1‏
919 ‎‡a riskofcancerrevealedbyfollowupoffamilieswithhereditarynonpolyposiscolorectalcancerreplytodrelufneto‏ ‎‡A Risk of cancer revealed by follow-up of families with hereditary non-polyposis colorectal cancer: Reply to Dr. Eluf-Neto‏ ‎‡9 1‏
919 ‎‡a roleofclinicalcriteriainthediagnosisofhereditarynonpolyposiscolorectalcancer‏ ‎‡A Role of clinical criteria in the diagnosis of hereditary non-polyposis colorectal cancer‏ ‎‡9 1‏
919 ‎‡a roleofclinicalcriteriainthediagnosisofhereditarynonpolyposiscolorectalcancerhnpccresultsofamultivariateanalysis‏ ‎‡A Role of clinical criteria in the diagnosis of hereditary non-polyposis colorectal cancer (HNPCC): results of a multivariate analysis.‏ ‎‡9 1‏
919 ‎‡a stage1colorectalcarcinomavegfimmunohistochemicalexpressionmicrovesseldensityandtheircorrelationwithclinicaloutcome‏ ‎‡A Stage I colorectal carcinoma: VEGF immunohistochemical expression, microvessel density, and their correlation with clinical outcome‏ ‎‡9 1‏
919 ‎‡a survivalanalysisinfamiliesaffectedbyhereditarynonpolyposiscolorectalcancer‏ ‎‡A Survival analysis in families affected by hereditary non-polyposis colorectal cancer‏ ‎‡9 1‏
919 ‎‡a survivalofcolorectalcancerpatientsineuropeduringtheperiod1978‏ ‎‡A Survival of colorectal cancer patients in Europe during the period 1978–1989‏ ‎‡9 1‏
919 ‎‡a suspectedhereditarynonpolyposiscolorectalcancer‏ ‎‡A Suspected hereditary nonpolyposis colorectal cancer‏ ‎‡9 1‏
919 ‎‡a whatshouldweadviseaboutalcoholconsumption‏ ‎‡A What should we advise about alcohol consumption‏ ‎‡9 1‏
919 ‎‡a understandingvariationsinsurvivalforcolorectalcancerineuropeaeurocarehighresolutionstudy‏ ‎‡A Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study‏ ‎‡9 1‏
943 ‎‡a 198x‏ ‎‡A 1989‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 BNCHL|10000000000000000025624‏
996 ‎‡2 NUKAT|n 2016083052‏
996 ‎‡2 LC|n 2021046275‏
996 ‎‡2 ISNI|0000000117793527‏
996 ‎‡2 NUKAT|n 2005089796‏
996 ‎‡2 PLWABN|9810680672005606‏
996 ‎‡2 LC|n 94801196‏
996 ‎‡2 ISNI|0000000044276405‏
996 ‎‡2 NUKAT|n 2004258329‏
996 ‎‡2 SUDOC|198321856‏
996 ‎‡2 NUKAT|n 2020123033‏
996 ‎‡2 ARBABN|000030395‏
996 ‎‡2 ISNI|0000000420113694‏
996 ‎‡2 BNF|14839050‏
996 ‎‡2 CAOONL|ncf10685306‏
996 ‎‡2 ISNI|0000000108773356‏
996 ‎‡2 ISNI|0000000028212399‏
996 ‎‡2 ISNI|0000000059168810‏
996 ‎‡2 BIBSYS|5037102‏
996 ‎‡2 NTA|264599349‏
996 ‎‡2 JPG|500722732‏
996 ‎‡2 LC|no2004059171‏
996 ‎‡2 SUDOC|068760582‏
996 ‎‡2 SUDOC|197591833‏
996 ‎‡2 NTA|436273829‏
996 ‎‡2 ISNI|0000000035605422‏
996 ‎‡2 LC|n 85025411‏
996 ‎‡2 LC|n 2005078789‏
996 ‎‡2 DNB|1056546042‏
996 ‎‡2 J9U|987009748361605171‏
996 ‎‡2 LC|n 97910185‏
996 ‎‡2 DNB|172792274‏
996 ‎‡2 ISNI|0000000061423139‏
996 ‎‡2 ISNI|0000000514249162‏
996 ‎‡2 BNE|XX4859293‏
996 ‎‡2 ISNI|0000000050852114‏
996 ‎‡2 BNCHL|10000000000000000827950‏
996 ‎‡2 LC|no2009045763‏
996 ‎‡2 BNC|981061116436006706‏
996 ‎‡2 LC|n 2009026522‏
996 ‎‡2 BIBSYS|90085864‏
996 ‎‡2 DNB|1020307234‏
996 ‎‡2 SUDOC|268604274‏
996 ‎‡2 PLWABN|9810634803005606‏
996 ‎‡2 NII|DA08676590‏
996 ‎‡2 DNB|1044411139‏
996 ‎‡2 NTA|167727710‏
996 ‎‡2 ISNI|0000000033494589‏
996 ‎‡2 RERO|A009631494‏
996 ‎‡2 NSK|000529980‏
996 ‎‡2 BIBSYS|90791909‏
996 ‎‡2 LC|no2008067316‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏